Effectiveness of a Psychoeducational Group Intervention in Patients With Depression and Physical Comorbidity (PsiCoDep)

May 29, 2019 updated by: Jordi Gol i Gurina Foundation

Effectiveness of a Psychoeducational Group Intervention Conducted by Primary Health Care Nurses in Patients With Depression and Physical Comorbidity

The primary aim is to evaluate the effectiveness of an intervention based on a psychoeducational program carried out by primary care nurses, to improve the rate of remission and response of depression in patients with physical chronic illness (diabetes, COPD, asthma and / or ischemic heart disease). Secondarily, to assess the cost-effectiveness of the intervention, the effectiveness to improve the control of physical pathology, the impact on quality of life and the feasibility of the intervention.

Methods: a multicentre, randomized clinical trial, with two groups and 1 year follow-up evaluation. Economic evaluation study. We will study 504 patients (252 in each group), over 50 years assigned to 25 primary care teams (PC) from Catalonia (urban, semi-urban and rural) with major depression and with at least one of the diseases: diabetes mellitus type 2, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease. They will be distributed randomly into two groups. The intervention group will participate in psychoeducational groups: 12 weekly 90-minute sessions led by two nurses from PC, consisting of health education on chronic physical illness and depressive symptoms.

Main measurements: clinical remission of depression and / or response to intervention (Beck depression inventory: BDI-II). Secondary measures: improvement in control of chronic disease (blood test and physical parameters), drug compliance (test Morinsky-Green and number of packaging), quality of life (EQ-5D), medical service utilization (appointments and hospital admissions due to complications) and feasibility of the intervention (satisfaction and compliance). Evaluations will be masked and conducted at 0, 3 and 12 months. At 6 months, patients will receive a call from nurses.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

504

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Santa Margarida de Montbui, Barcelona, Spain, 08710
        • Centre d'Atenció Primària (CAP) Santa Margarida de Montbui

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Presence of at least one of the following diseases: type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease.
  • Meet major depression criteria at the time of the study: Score above 13 on the BDI-II scale.
  • Possibility of follow-up of one year by the same primary care team.
  • At least read and write Spanish or Catalan.

Exclusion Criteria:

  • Diagnosis of dementia or moderate or high cognitive impairment (5 or more errors according to the pfeiffer scale).
  • Major depression with psychotic symptoms or with other serious psychiatric comorbidities.
  • Moderate or high risk of suicide (6 or more points on the MINI suicide scale).
  • Dependency disorders due to alcohol or other drug abuse.
  • Advanced stage physical disease.
  • Inability to travel to the center.
  • Be receiving some psychological therapy by the Center of mental health (CSM) of reference

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention Group

The intervention group will participate in psychoeducational groups: 12 weekly 90-minute sessions led by two nurses from Primary Care, consisting of health education on chronic physical illness and depressive symptoms.

Group psychoeducation.

Educational group sessions for patients with depression and physical comorbidities in order to improve the degree of control of their illnesses
NO_INTERVENTION: Control Group
Usual clinical care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in rate of remission of depression
Time Frame: At 12 months of follow-up
Changes in the score of the BDI-II scale
At 12 months of follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in rate of remission of depression
Time Frame: At 3 months of follow-up
Changes in the score of the BDI-II scale
At 3 months of follow-up
Changes in the control of DM2
Time Frame: At 12 months of follow-up
Changes in HbA1c
At 12 months of follow-up
Changes in the control of COPD
Time Frame: At 12 months of follow-up
Changes in FEV1
At 12 months of follow-up
Changes in the control of asthma
Time Frame: At 12 months of follow-up
Changes in FEV1
At 12 months of follow-up
Changes in the control of Ischemic heart disease
Time Frame: At 12 months of follow-up
Changes in LDL cholesterol
At 12 months of follow-up
Referrals to mental health
Time Frame: At 12 months of follow-up
Number of visits to mental health centers
At 12 months of follow-up
Record of therapeutic compliance
Time Frame: At 12 months of follow-up
Morisky-Green test
At 12 months of follow-up
Changes in the quality of life
Time Frame: At 12 months of follow-up
Measured by the EuroQol scale (EQ-5D)
At 12 months of follow-up
Quantification of the use of services
Time Frame: At 12 months of follow-up
Number of hospital admissions
At 12 months of follow-up
Satisfaction with the intervention
Time Frame: At 3 months of follow-up
Survey at the end of the intervention
At 3 months of follow-up
Adherence to the intervention
Time Frame: At 3 months of follow-up
Number of assisted sessions
At 3 months of follow-up
Qualitative changes of the state of mind at the end of the intervention
Time Frame: At 3 and 12 months of follow-up
better, equal or worse
At 3 and 12 months of follow-up
Qualitative changes of the state of health at the end of the intervention
Time Frame: At 3 and 12 months of follow-up
better, equal or worse
At 3 and 12 months of follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 6, 2017

Primary Completion (ANTICIPATED)

June 1, 2019

Study Completion (ANTICIPATED)

December 1, 2019

Study Registration Dates

First Submitted

July 25, 2017

First Submitted That Met QC Criteria

August 4, 2017

First Posted (ACTUAL)

August 9, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 31, 2019

Last Update Submitted That Met QC Criteria

May 29, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PI16/01272

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Disorder

Clinical Trials on Group psychoeducation

3
Subscribe